Education
About Us
Working with TipRanks
Follow Us
Ashland Global Holdings, Inc. (ASH)
NYSE:ASH
Earnings Data
Report Date
May 05, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
1.05Last Year’s EPS
0.99Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents a cautiously optimistic tone: several core strengths (robust cash generation, strong liquidity, Life Sciences growth, margin improvements in key segments, and tangible innovation/Globalize traction) contrast with near-term operational disruptions (Calvert City outage, weather impacts), pockets of weak end-market demand (China coatings, Intermediates), and modest pricing pressure. Management articulated clear cost-savings and transformation levers and maintained full-year adjusted EBITDA guidance while acknowledging that some issues will delay recovery into Q3/Q4. Overall, underlying business progress and financial resilience appear to outweigh the temporary operational and regional demand challenges.Company Guidance
Strong cash generation and liquidity
Operating cash flow of $125 million in Q1 and ongoing free cash flow of $26 million; free cash flow conversion nearly 50% in a seasonally low quarter. Total liquidity approximately $900 million and net leverage 2.7x (net debt $1.1 billion).
Life Sciences outperformance
Life Sciences sales $139 million, up 4% year-over-year; adjusted EBITDA $31 million, up 11% YoY. Segment margin expanded to 22.3%, a 140 basis point improvement, supported by resilient pharma demand, injectables growth, tablet coatings double-digit growth, and contributions from low-nitride/high-purity excipients.
Margin recovery in Specialty Additives despite volume headwinds
Specialty Additives sales were down 11% YoY ($102 million), but adjusted EBITDA rose 15% to $15 million and EBITDA margin expanded 340 basis points to 14.7%, driven by cost efficiencies (HCC consolidation) and productivity improvements.
Innovation and Globalize traction
Delivered $6 million of incremental innovation sales toward a $15 million goal and $3 million of incremental Globalize sales toward a $20 million goal; Globalize business lines grew 8% year-to-date. New product contributions included approx. $5 million in Specialty Additives and several launches across Life Sciences and Personal Care (TVO platforms, low nitride cellulosics, Colipepto, Lubrihands).
Disciplined cost actions and productivity progress
Structural portfolio and manufacturing optimization actions improving margins and mix. Fiscal 2026 cost savings target (~$30 million) remains on track; overall manufacturing/network savings target $50–55 million (upside to $60 million) intact. $90 million transformation program progressing (25 achieved in FY25, 30 committed for FY26).
Adjusted operating income growth
Adjusted operating income increased 27% year-over-year, reflecting lower depreciation & amortization from optimization actions and underlying business stability.
Personal Care stable with high-value growth areas
Personal Care organic sales down only 1% ex-Evoqua divestiture (reported sales $123 million, down 8% largely due to ~7% Evoqua divestiture). Biofunctional actives grew double digits and microbial protection gained share with above-market volume growth.
Maintained full-year EBITDA guidance range
Narrowed fiscal 2026 adjusted EBITDA guidance to $400 million–$420 million while acknowledging short-term operational impacts; management emphasizes second-half weighted recovery potential.
ASH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ASH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 02, 2026 | $61.56 | $61.08 | -0.78% |
Nov 04, 2025 | $47.46 | $50.34 | +6.06% |
Jul 29, 2025 | $49.42 | $52.18 | +5.58% |
Apr 30, 2025 | $53.13 | $47.90 | -9.85% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Ashland Global Holdings, Inc. (ASH) report earnings?
Ashland Global Holdings, Inc. (ASH) is schdueled to report earning on May 05, 2026, After Close (Confirmed).
What is Ashland Global Holdings, Inc. (ASH) earnings time?
Ashland Global Holdings, Inc. (ASH) earnings time is at May 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ASH EPS forecast?
ASH EPS forecast for the fiscal quarter 2026 (Q2) is 1.05.
